Literature DB >> 27200867

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Ankylosing Spondylitis (As).

M Govoni1, R Lyu2, Q Ding3, T Fan2.   

Abstract

Entities:  

Year:  2014        PMID: 27200867     DOI: 10.1016/j.jval.2014.08.2635

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Persistence with biological drugs in patients treated in rheumatology practices in Germany.

Authors:  Louis Jacob; Thomas Chevalier; Karel Kostev
Journal:  Rheumatol Int       Date:  2018-11-24       Impact factor: 2.631

2.  Persistence and treatment-free interval in patients being prescribed biological drugs in rheumatology practices in Germany.

Authors:  Karel Kostev; Louis Jacob
Journal:  Eur J Clin Pharmacol       Date:  2019-01-21       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.